Moderna to seek emergency FDA authorization for coronavirus vaccine

Moderna said it would apply for emergency FDA approval for its coronavirus vaccine on Monday, making it the second developer to do so. It will also apply for conditional marketing authorization from the European Medicines Agency.

The final results of Moderna’s late-stage vaccine study involving 30,000 people show the shot is 94.1 percent effective, the company said.

Leave a Comment